Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has retired a note, principal amount $160,000, in its continuing effort to reduce debt.
The convertible debenture was held by Tangiers Investors, LP, San Diego, California. "We told our stakeholders and potential investors that a major effort would be made throughout this year to reduce debt and strengthen our balance sheet. This is another example of fulfilling that commitment," said Matthew Schissler, co-founder and CEO.
Cord Blood America previously announced that, through August of 2009, it had reduced its secured debt by $6.6 million.
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking